Pharmaceutical company Sun Pharma is set to release its first-quarter earnings today. A weak set of numbers is expected for the company this quarter.
Revenues are expected to decline by 3.5 percent while EBITDA is likely to decline by 21 percent. Margins are expected to contract by 400 bps to 19.6 percent while profit could take a hit of around 34 percent.Factors to watch:
- The US business will be impacted due to a hit on the specialty portfolio.
- The India business is expected to decline by 5 percent.
- Some weakness seen in other markets as well.
- EBITDA margins will decline because of higher R&D expenses this time.